AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more.

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

What happens when freezers fail? Experts look at the lessons that can be learned from catastrophic power outages.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.